Company Overview

Update
Founded:
October 7, 2011
Founders:
Albert Ho, Foster Sayers
Headquarters:
Providence, RI
Funding:
$794k
Categories:
Personalization, Technology, Medical Devices, See All (6)

121nexus offers cloud-based track and trace solutions, integrated with product packaging, for biomedical manufacturers.

Description

Update

121nexus deploys cloud-based track & trace solutions for biomedical manufacturers. A recent report prepared by McKinsey & Co estimates that the cost of medical errors introduced by inadequate track & trace on medical devices is estimated to be between $18 and $115 billion annually. In response to the need in the industry for such a track & trace solution, 121nexus developed MDDTrack™, which is a cloud-based software solution for manufacturers to enhance recall management and post-market surveillance in the medical devices and diagnostics industry.

121nexus' technology solves a problem so critical to public health that it was awarded a National Science Foundation grant to accelerate commercialization of this unique approach to biomedical track & trace. The core technology has been claimed in US Patent 8,533,075, US Patent applications 13/792,651 and 13/925,039, and International application PCT/US14/10293.

Current Team (2)

Update

Products (4)

Update
  • Cb default image

    121 Campaign™

    121 Campaign™ was launched in 2012
  • Cb default image

    MDDTrack™

    MDDTrack™ is a patented technology for Unique Device Identification (UDI) that provides complete..
  • Cb default image

    IFUTrack™

    IFUTrack™ is our solution for publishing electronic instructions for use in compliance with the..
  • Cb default image

    PharTrack™

    PharTrack™ is a cloud-based solution for drug product safety, security, and education. The..

Funding Rounds (6) - $794k

Update

Investors (6)

Update

Offices/Locations (2)

Update
  • Office

    Boston, MA 02127

    USA

  • Office

    Providence, RI 02903

    USA